PARIS (Reuters) -Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S.

Sanofi said it entered talks to sell a controlling stake in consumer health business Opella to private-equity firm Clayton ...

Sanofi is nearing the sale of its consumer health business to Clayton Dubilier & Rice, a year after Chief Executive Officer ...

Business CDs are like regular CDs—they can help you earn more on your business savings. Learn how they work and whether ...

With interest rates dropping, experts expect more financial institutions to start calling back high yielding CDs. What that means and what you can do.

Sanofi said it entered into talks with Clayton Dubilier & Rice to offload a controlling stake in its consumer-health division, leaning toward a partial sale to a private-equity firm rather than a ...

Sanofi on Friday said it’s in talks with the private equity firm CD&R to sell just over half of its consumer healthcare ...

Sanofi to sell consumer health unit for $16.4 billion to private equity firm Clayton Dubilier & Rice in upcoming deal ...

Instead, if you aren’t able to keep your money locked for the certificate’s entire term, you must sell your CD on the secondary market. Note the potential costs involved in selling your CD.

Instead, you would sell your CD on the secondary market if you needed the money before your term ends. If you're looking to use CDs as part of your savings strategy, Edward Jones' brokered CDs may ...

you'll sell your CD on the secondary market. Brokered CDs typically offer flexible terms and higher interest rates than traditional CDs, but they do not compound interest. With Schwab CDs ...